電気生理学デバイスの市場規模、シェア、成長分析、タイプ別、適応症別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

電気生理学デバイス市場規模は2023年に68億米ドルと評価され、2024年の74億4,000万米ドルから2032年には152億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.4％で成長する見通しです。

電気生理学（EP）市場は、心房細動（AF）のような心臓疾患の有病率の上昇と高度な心臓モニタリング機器への需要に牽引されて大きな成長を遂げています。その要因としては、ミレニアル世代における不健康なライフスタイルの選択が挙げられ、CDCの予測では2031年までに約1,210万人の米国人が心房細動に罹患すると推定されています。特に欧州では心房細動に対する感受性が高く、突然の心停止は欧米諸国における主要な死因となっています。この市場は、植え込みデバイスの遠隔追跡やワイヤレス技術によるデータ管理など、モバイル心臓モニタリングの進歩によってさらに活性化し、重要な患者情報へのアクセスが強化されます。最近のFDA承認に代表される低侵襲処置や革新的技術への動向は、ヘルスケアプロバイダーがより良い不整脈管理のためにEP機器を採用することで、この分野の有望な見通しを強調しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術分析

電気生理学デバイス市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• アブレーションカテーテル
• 診断用カテーテル
• マッピングシステム
• アクセサリー
• その他

電気生理学デバイス市場規模：適応症別& CAGR（2025-2032）

• 市場概要
• 心房細動（AF）
• 房室結節リエントリー性頻拍（AVNRT）
• 上室性頻拍
• 徐脈
• ウォルフ・パーキンソン・ホワイト症候群（WPW）
• その他

電気生理学デバイス市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 診断装置
  • 診断用電気生理学カテーテル
  • ホルター心電図モニタリング装置
  • EPマッピングおよびイメージングシステム
  • 心電図（ECG）
  • 挿入型心臓モニター（ICM）
  • その他
• 治療機器
  • 自動体外除細動器（AED）
  • 植込み型除細動器（ICD）
  • CRT-D
  • CRT-P
  • カテーテル
  • ペースメーカー
  • その他

電気生理学デバイス市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来手術センター
• その他

電気生理学デバイス市場規模& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Medtronic plc（Ireland）
• GE Healthcare（USA）
• Siemens Healthineers（Germany）
• Koninklijke Philips N.V.（Netherlands）
• MicroPort Scientific Corporation（China）
• Nihon Kohden Corporation（Japan）
• Stereotaxis, Inc.（USA）
• Biosense Webster, Inc.（USA）
• Biotronik SE & Co. KG（Germany）
• CardioFocus, Inc.（USA）
• CathVision ApS（Denmark）
• Japan Lifeline Co., Ltd.（Japan）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• Osypka AG（Germany）
• Pentax Medical（Japan）
• Shanghai MicroPort EP MedTech Co., Ltd.（China）
• Teleflex Incorporated（USA）
• Topera, Inc.（USA）

結論と提言

Electrophysiology Devices Market size was valued at USD 6.8 billion in 2023 and is poised to grow from USD 7.44 billion in 2024 to USD 15.26 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

The electrophysiology (EP) market is experiencing significant growth driven by the rising prevalence of heart diseases like atrial fibrillation (AF) and the demand for advanced cardiac monitoring equipment. Contributing factors include unhealthy lifestyle choices among millennials, with predictions from the CDC estimating approximately 12.1 million Americans affected by AF by 2031. Notably, Europeans exhibit a higher susceptibility to AF, with sudden cardiac arrest being a leading cause of death in Western nations. The market is further fueled by advancements in mobile cardiac monitoring, including remote tracking of implanted devices and data management through wireless technology, enhancing access to critical patient information. The trend towards minimally invasive procedures and innovative technologies, exemplified by recent FDA approvals, underscores the sector's promising outlook as healthcare providers adopt EP devices for better arrhythmia management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Electrophysiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Electrophysiology Devices Market Segments Analysis

Global Electrophysiology Devices Market is segmented by Type, Indication, Application, End-user and region. Based on Type, the market is segmented into Ablation Catheters, Diagnostic Catheters, Mapping System, Accessories and Others. Based on Indication, the market is segmented into Atrial Fibrillation (AF), Atrioventricular Nodal Re-entry Tachycardia (AVNRT), Supraventricular Tachycardia, Bradycardia, Wolff-Parkinson-White Syndrome (WPW) and Others. Based on Application, the market is segmented into Diagnostic Devices and Treatment Devices. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Electrophysiology Devices Market

The increasing incidence of cardiac arrhythmias, particularly atrial fibrillation and ventricular tachycardia, significantly propels the electrophysiology devices market. As these heart conditions become more common, the demand for precise diagnostic and therapeutic solutions rises. Electrophysiology devices play a crucial role in managing these disorders by providing essential tools for both accurate assessment and effective treatment options. The need to address the complications associated with arrhythmias is driving innovation and investment in this market, leading to advancements in device technology and enhanced patient care. Consequently, the ongoing rise in arrhythmia cases is a key impetus behind the growth of this sector.

Restraints in the Electrophysiology Devices Market

The Electrophysiology Devices market faces significant constraints due to the high costs associated with these advanced technologies. This financial barrier can hinder their widespread adoption, particularly in areas with constrained healthcare budgets or within healthcare systems that enforce strict reimbursement policies. A considerable upfront investment is required for these devices, making them less accessible to healthcare providers in economically challenged regions. Consequently, the elevated price tag acts as a critical restraint on market growth, limiting the ability to integrate these essential tools into clinical practice, thereby impacting patient care and treatment outcomes in various healthcare settings.

Market Trends of the Electrophysiology Devices Market

The electrophysiology devices market is increasingly favoring minimally invasive procedures, driven by technological advancements and innovative device designs. These catheter-based techniques facilitate accurate diagnosis and treatment of cardiac arrhythmias with significantly improved patient outcomes, including reduced discomfort, shorter recovery periods, and lower complication rates. As healthcare providers and patients alike prioritize less invasive interventions, the demand for electrophysiology devices that support these methods is poised for substantial growth. This trend not only enhances procedural efficiency but also aligns with the broader shift towards patient-centered care in the medical field, indicating a promising future for this segment of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Electrophysiology Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Ablation Catheters
• Diagnostic Catheters
• Mapping System
• Accessories
• Others

Global Electrophysiology Devices Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Atrial Fibrillation (AF)
• Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
• Supraventricular Tachycardia
• Bradycardia
• Wolff-Parkinson-White Syndrome (WPW)
• Others

Global Electrophysiology Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostic Devices
  • Diagnostic Electrophysiology Catheters
  • Holter Monitoring Devices
  • EP Mapping & Imaging Systems
  • Electrocardiograph (ECG)
  • Insertable Cardiac Monitors (ICM)
  • Others
• Treatment Devices
  • Automated external defibrillators (AEDs)
  • Implantable Cardioverter Defibrillators (ICDs)
  • CRT-D
  • CRT-P
  • Catheters
  • Pacemakers
  • Others

Global Electrophysiology Devices Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory surgical centers
• Others

Global Electrophysiology Devices Market Size & CAGR (2025-2032)

• North America (Type, Indication, Application, End-user)
  • US
  • Canada
• Europe (Type, Indication, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stereotaxis, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosense Webster, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioFocus, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CathVision ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Japan Lifeline Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pentax Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai MicroPort EP MedTech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topera, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations